Skip to content

Impact of Estazolam on Comorbid Pain and Knee Functions in Total Knee Arthroplasty Patients Diagnosed with Anxiety:A Prospective Randomized Controlled Study

Impact of Estazolam on Comorbid Pain and Knee Functions in Total Knee Arthroplasty Patients Diagnosed with Anxiety:A Prospective Randomized Controlled Study

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500099545
Enrollment
Unknown
Registered
2025-03-25
Start date
2025-04-01
Completion date
Unknown
Last updated
2025-03-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Knee osteoarthritis

Interventions

A(Experimental):Perioperative standard care protocol + oral estazolam 2 mg per dose administered three times daily, initiated one day preoperatively and continued through postoperative day 10.
B (Control):Perioperative standard care protocol + matched oral placebo (2 mg per dose, three times daily), administered following the same schedule as Group A.
C(Non-anxiety Cohort):Perioperative standard care protocol without additional pharmacological intervention.

Sponsors

Xi'an Honghui Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
50 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1)Patients with an American Society of Anesthesiologists(ASA)physical status classification of I-III. (2)Preoperative diagnosis of primary osteoarthritis of the knee,with symptoms predominantly on one side and refractory to conservative treatment. (3) Scheduled for unilateral total knee arthroplasty (TKA); (4) Age =18 years; (5) No history of severe psychiatric disorders or drug dependence. (6) Willingness to provide written informed consent and ability to comply with study protocols.

Exclusion criteria

Exclusion criteria: (1) Patients undergoing bilateral knee replacement, ipsilateral hip and knee replacement, or perioperative surgery at other sites; (2) History of major stress events within 1 month before surgery, including major trauma, significant illness, surgery, or major family crises; (3) Concomitant major diseases such as malignancy, active infection, or other systemic diseases that may confound study outcomes; (4) History of psychiatric disorders, use of psychotropic medications, or severe anxiety; (5) History of dependence on anesthetic agents or substance abuse; (6) Inability to obtain reliable medical history due to communication barriers, language disorders, or non-compliance with data collection; (7) Contraindications to estazolam use, including hypersensitivity to benzodiazepines, glaucoma, or hepatic/renal impairment.

Design outcomes

Primary

MeasureTime frame
Pain;Knee Functions;ROM;

Countries

China

Contacts

Public ContactHuang Yuanchi

Xi'an Honghui Hospital

huangychell@163.com+86 136 8917 4320

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026